ArticleBlood advances2026

Primary refractory disease in large B-cell lymphoma: definition and outcomes from a secondary analysis of the LY.12 clinical trial.

Inna Y Gong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.